Sonographically Guided Posterior Subtalar Joint Injections via the Sinus Tarsi Approach by Smith, Jay et al.
Sonographically Guided Posterior 
Subtalar Joint Injections via the Sinus
Tarsi Approach
he posterior subtalar joint (PSTJ) is a well-documented
source of ankle and hindfoot pain and may result in con-
siderable disability.1–10 The role of diagnostic and thera-
peutic PSTJ injections has been firmly established in clinical
practice.1,2,8,9,11–13 Due to the complex and often pathologically dis-
torted anatomy of the PSTJ, image guidance is commonly recom-
mended to ensure accurate needle placement within the PSTJ.1,2,9,14,15
Although computed tomographic (CT) and fluoroscopic guidance
has been successfully used for this purpose, 3 sonographically
guided PSTJ injection techniques have recently been described and
validated in cadaveric investigations.5,9,10,14–17 Despite the fact that
sonography provides the advantages of portability, procedural
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ORIGINAL RESEARCH
Objectives—To determine the feasibility and accuracy of sonographically guided posterior
subtalar joint (PSTJ) injections performed through the sinus tarsi.
Methods—A single experienced operator completed 10 sonographically guided
PSTJ injections via the sinus tarsi on 10 unembalmed cadaveric ankle-foot specimens.
Injections were performed using a 17–5-MHz linear transducer, a 25-gauge, 50-mm
needle, and an out-of-plane, anterior-to-posterior needle trajectory parallel to the cal-
caneal surface. Sonographic assessment for fluid in the posterior and lateral PSTJ
recesses, sinus tarsi, and peroneal tendon sheath was performed before and after injections
of 2 and 4 mL of tap water. Two additional specimens were injected with a contrast agent:
1 via the sonographically guided approach and another by a computed tomographically
guided approach.
Results—All 10 sonographically guided PSTJ tap water injections were accurate,
distending both the posterior and lateral PSTJ recesses. In addition, all 10 specimens
showed posterior recess distension by 2 mL, whereas only 2 specimens (20%) showed
lateral recess distension at this volume. By 4 mL, both recesses were clearly distended
in all specimens. Both contrast agent injections produced similar PSTJ computed tomo-
graphic arthrograms and patterns of recess distension similar to the sonographically
guided tap water injections. No sonographically guided PSTJ injection placed fluid in
the peroneal tendon sheath.
Conclusions—Sonographically guided PSTJ injections via the sinus tarsi can accurately
and specifically deliver injectate into the PSTJ while monitoring injectate flow within the
posterior recess. The sinus tarsi approach may be used as an alternative technique to
perform sonographically guided PSTJ injections when clinically appropriate. 
Key Words—ankle; injection; musculoskeletal ultrasound; sinus tarsi; sonography;
subtalar
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flexibility, and lack of ionizing radiation, published sono-
graphically guided PSTJ techniques are not without limi-
tations.5,10,18,19 The posteromedial approach requires
needle passage in close proximity to the tibial neurovascu-
lar bundle.5 The posterolateral approach may be techni-
cally challenging due to the ergonomics of targeting the
deeply located posterior PSTJ recess and may result in
inadvertent puncture of the flexor hallucis longus tendon
sheath.5 Although the anterolateral approach targeting the
lateral PSTJ recess was preferred by the authors of the pre-
vious study and has been successful in clinical practice, 
the narrow acoustic window for needle passage may render
the described out-of-plane needle approach challenging in
some clinical circumstances.5,10 It is also noteworthy that
prior authors have highlighted the fact that image-guided
injections targeting the lateral PSTJ recess may be impeded
by congenital (eg, fibular overhang), degenerative (eg,
osteophytes and narrowing) or postsurgical (eg, hardware)
changes in this region.6,9,10
The sinus tarsi is a cone-shaped opening in the
anterolateral ankle located between the talar neck and
anterosuperior calcaneus.7,8,13,20–22 The sinus tarsi extends
posteromedially, where it transitions into the tarsal canal and
eventually exits above the sustentaculum tali.8,13 The con-
tents of the sinus tarsi include fibrofatty tissue containing
a fine neurovascular network and several ligamentous
structures that function to control talocalcaneal motion
and stability: the cervical ligament, interosseous talocal-
caneal ligament, and medial and intermediate roots of the
inferior extensor retinaculum.7,8,13,20,23 The sinus tarsi is
bordered posteriorly on its calcaneal side by the PSTJ,
which is separated from the sinus tarsi by a capsule and in
more than 95% of cases a relatively thick (1.4 ± 0.4 mm)
anterior capsular ligament.20 Although the sinus tarsi is typ-
ically discussed in the context of sinus tarsi syndrome, sub-
talar instability, or periarticular ganglion cysts, it also provides
potential access to the PSTJ for diagnostic or therapeutic
injections. However, to our knowledge, techniques to inject
the PSTJ via the sinus tarsi have not been formally described.
The primary purpose of this investigation was to
describe and validate a technique for sonographically guided
PSTJ injections performed via the sinus tarsi. On the basis
of the known regional anatomy and our preliminary cadav-
eric and clinical experience, we hypothesized that the PSTJ
could be injected with 100% accuracy through the sinus
tarsi, as demonstrated in a cadaveric model. Validating the
sonographically guided PSTJ injection technique via the
sinus tarsi approach would have 2 important clinical impli-
cations: (1) provide an alternative route for accurate PSTJ
injections when more traditional PSTJ injection approaches
are either not feasible or undesirable; and (2) provide the
opportunity for combined PSTJ and sinus tarsi injections
using a single needle when clinically indicated.
Materials and Methods
General Design
The study consisted of 2 parts, a sonographic component
and a CT component. For the sonographic component, the
primary investigator (J.S.) performed sonographically
guided PSTJ injections via the sinus tarsi approach on 10
unembalmed cadaveric ankle-foot specimens while moni-
toring PSTJ recess distension sonographically. All 10 injec-
tions were completed in the Mayo Clinic Procedural Skills
Laboratory, and the primary investigator had more than 8
years of experience in diagnostic and interventional mus-
culoskeletal sonography at the time of the investigation.
For the second part of the study, 2 additional specimens
were injected in the Mayo Clinic Opus Imaging Research
Facility, where CT scanning was available. On the first spec-
imen, the primary investigator performed a single sono-
graphically guided PSTJ injection via the sinus tarsi using
a diluted iodinated contrast agent. On the second, a study
coinvestigator (N.S.M.), a board-certified, musculoskeletal
fellowship-trained radiologist with experience in CT-guided
ankle-foot injections, performed a CT-guided PSTJ contrast
agent injection from a lateral approach.16 Contrast flow
patterns were assessed with CT. All anatomic specimens
for both parts of the investigation were obtained through
the Department of Anatomy’s Mayo Foundation Bequest
Program, were fully thawed at room temperature immedi-
ately before use, and were free of signs of surgery, trauma, or
major deformity around the foot and ankle region. This
research was approved by the Mayo Clinic’s Bio-Specimens
Subcommittee of the Institutional Review Board.
Anatomic Specimens
A total of 12 unembalmed cadaveric ankle-foot specimens
were used for this investigation. Age, sex, body mass index
(BMI), and side (left, right, or both) were recorded for
each donor. Specimens were obtained on the basis of avail-
ability and therefore were not necessarily paired (ie, left
and right ankle-foot specimens from the same donor). 
In addition, no specific measures were taken to ensure an
equal number of left and right ankle-foot specimens.
Equipment
The 10 primary sonographically guided PSTJ injections
performed in the Procedural Skills Laboratory were com-
pleted using an iU22 ultrasound machine and a 17–5-MHz
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linear array transducer (Philips Healthcare, Bothell, WA).
The sonographically guided PSTJ injection performed for
CT validation was completed using a CX50 portable ultra-
sound machine and a 12–3-MHz linear array transducer
(Philips Healthcare). The CT-guided PSTJ injection and
the CT scans after both the sonographically guided
and CT-guided injections were performed using a Sensation
64 scanner (GE Healthcare, Waukesha, WI) with the
following parameters: collimation, 12 × 0.3 mm; pitch, 0.8;
reconstruction slice and increment, 0.4 to 0.6 and 0.2 to 0.6
mm; tube voltage, 140 kV (peak); and tube current, 250
mA. All injections were performed using 25-gauge, 38- or
50-mm stainless steel needles.
Sonographically Guided PSTJ Injections via the Sinus
Tarsi
The primary investigator (J.S.) completed all sonographi-
cally guided PSTJ injections during this investigation.
Although traditional sinus tarsi injections direct the needle
parallel to the sinus tarsi and tarsal canal, from anterolateral
to posteromedial, a preliminary investigation determined
that this trajectory was not reliable for PSTJ access.4,21
An anterior-to-posterior trajectory maintaining the needle
parallel and superjacent to the calcaneus was subsequently
determined to optimally direct the needle through the
anterior aspect of the PSTJ and was therefore used for this
study (Figure 1).
The procedure for the sonographically guided PSTJ
injection via the sinus tarsi is shown in Figure 2. To perform
the PSTJ injection, the ankle-foot specimen was first placed
in a relaxed position of plantar flexion and inversion.
The posterior PSTJ recess, lateral PSTJ recess, and per-
oneal tendon sheath were imaged using light transducer
pressure to document any baseline fluid. Thereafter, the
sinus tarsi was either directly palpated or identified by scan-
ning proximally from the third intermetatarsal space, as
previously described.21 In either case, the bony calcaneal
and talar margins were visualized with the transducer in
a coronal oblique plane at the level of the sinus tarsi.
Thereafter, the transducer was repositioned and the image
adjusted to provide the best view of the sinus tarsi’s depth
and its lateral calcaneal margin. The presence of any base-
line fluid was recorded. A 25-gauge, 50-mm stainless steel
needle attached to a 12-mL syringe was then advanced
using an out-of-plane, anterior-to-posterior approach into
the sinus tarsi. The needle trajectory was chosen to
pass the needle just superficial and parallel to the superior
aspect of the calcaneus. Once the needle advanced to the
depth, the tip often became challenging to visualize.
Although tip visualization could be obtained via fine trans-
ducer manipulation in the out-of-plane view or by switching
to an in-plane view, it was deemed unnecessary, as bone
contact typically occurred as needle tip visualization dete-
riorated. At this point, the needle tip was directed through
the anterior capsule of the PSTJ, and the capsular pene-
tration was generally easily perceived.
Once the needle penetrated the anterior PSTJ capsule,
2 mL of normal tap water was injected under low pressure,
followed by rescanning of the recesses, sinus tarsi, and
peroneal tendon sheath using light transducer pressure.
The presence of any fluid-induced distension was assessed
qualitatively by visually determining whether the recess
had enlarged relative to baseline. Thereafter, without
changing the needle position, an additional 2 mL of normal
tap water were injected (for a total of 4 mL). At this point,
the recesses, sinus tarsi, and peroneal tendon sheath were
rescanned and results recorded. In addition, distension of
J Ultrasound Med 2015; 34:83–93 85
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Figure 1. Anatomic drawing of the superior calcaneal surface viewed
from above after removal of the talus, showing the calcaneal facets con-
tributing to the PSTJ and ASTJ. The ASTJ consists of middle and anterior
facets, which are continuous (as depicted in this drawing). The sinus
tarsi and tarsal canal separate the ASJT and PSTJ. The green arrow
depicts the typical anterolateral-to-posteromedial needle trajectory used
for a sinus tarsi injection. This trajectory approximates the direction of the
tarsal canal and may therefore miss the PSTJ. The red arrow depicts the
anterior-to-posterior needle trajectory used in this investigation to inject
the PSTJ via the sinus tarsi. Note the expected needle passage through
the extensor digitorum brevis (EDB) en route to the anterior aspect of
the PSTJ. Additional shaded areas represent attachments of ligamen-
tous structures associated with the sinus tarsi region. Bottom is poste-
rior; left, medial; right, lateral; and top, anterior.
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the middle facet of the anterior subtalar joint (ASTJ) was
sonographically assessed as a control. The ASTJ, also
known as the talocalcaneonavicular joint, is separated from
the PSTJ by the sinus tarsi and tarsal canal (Figure 1).
Although the ASTJ, sinus tarsi contents, and PSTJ com-
bine to form the subtalar or talocalcaneal joint complex,
the ASTJ is anatomically distinct from the PSTJ; therefore,
injectate placed into the PSTJ would not be expected to
appear in the ASTJ. 
Computed Tomographic Assessment of PSTJ Injection
For the CT portion of the investigation, 2 additional
cadaveric specimens were used. In the first specimen, the
primary investigator (J.S.) completed a sonographically
guided PSTJ injection using the technique described above
combined with extension tubing to inject 20% diluted
iohexol (Omnipaque 300; GE Healthcare) into the PSTJ.
Computed tomographic scanning was performed before
injection and after 2- and 4-mL total volume injections.
Smith et al—Sonographically Guided Posterior Subtalar Joint Injections
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Figure 2. A, Setup for sonographically guided PSTJ injection via the sinus tarsi approach. The transducer is placed across the sinus tarsi, bridging
between the talar neck and the superior calcaneus. The needle is advanced using an out-of-plane, anterior-to-posterior approach, keeping the needle
on the calcaneal side of the sinus tarsi. B, Corresponding sonographic view of a PSTJ injection via the sinus tarsi. The funnel-shaped opening of the
sinus tarsi is bordered by the calcaneus (CALC) and talus (TAL). The yellow arrow identifies the echogenic tip of the 25-gauge stainless steel needle
en route to the anterior aspect of the PSTJ. Note that the needle tip courses just adjacent to the calcaneal surface. The needle is advanced along this
trajectory until encountering bone, which represents the entry point into the PSTJ. Bottom is deep/posterior; left, superior/dorsal; right, inferior/
plantar; and top, superficial/anterior. C, Depiction of the needle trajectory relative to sonographically identifiable bony acoustic landmarks. Once again,
note the needle passage adjacent and superficial to the superior calcaneal surface. The needle tip has been placed into the PSTJ. The white arrow indi-
cates the posterior aspect of the PSTJ, formed by the posterior process of the talus and the superior calcaneal surface. Distension of the posterior recess
in this region can be used to confirm accurate needle placement (see “Materials and Methods,” “Discussion,” and Figure 3). Compare with A and D.
C indicates calcaneus; Cb, cuboid; Cn, cuneiform; F, fibula; T, tibia; and Ta, talus. D, Sagittal anatomic specimen correlating with C. The asterisk indi-
cates the sinus tarsi. The needle has been placed into the PSTJ via the sinus tarsi. The black arrow represents the medial root of the inferior extensor
retinaculum.
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The purpose of these injections was to show via CT
arthrography that the PSTJ injection via the sinus tarsi pro-
duces a typical PSTJ CT arthrogram.
In the second specimen, an experienced study coinves-
tigator (N.S.M.) completed a single CT-guided PSTJ injec-
tion in an additional specimen using a lateral approach, as
described by Saifuddin and colleagues.16 The hindfoot was
placed with the medial side down on the CT scanner table
and the plantar surface of the foot positioned parallel to the
side of the scanner table. A preliminary scan was taken
through the hindfoot with an overlying skin marker to pre-
cisely identify the lateral opening of the PSTJ. The CT
scanner table was brought to the exact position where the
PSTJ was best seen in the CT images and marked on the
skin surface using the laser crossbeam. A 25-gauge, 38-
mm stainless steel needle was then advanced into the lateral
aspect of the PSTJ using CT guidance. Once the needle
position was confirmed, a 12-mL syringe with short exten-
sion tubing containing a 20% dilution of Omnipaque 300
was injected into the PSTJ at 2-mL increments until a total
volume of 6 mL had been injected. Although the aver-
age volume of the native PSTJ has been estimated to range
from 3 to 5 mL, we intentionally completed a 6-mL total
volume injection to maximally distend all recesses in this
single specimen.8,9,13 During the injection sequence, as was
the case for the sonographically guided PSTJ contrast agent
injection, CT images were obtained to document contrast
flow after each 2-mL incremental injection. The purpose
of this injection was to prove that the PSTJ CT arthrogram
obtained using a well-accepted CT-guided approach is
similar to that obtained using the sonographically guided
sinus tarsi approach.
Assessment
The accuracy of the 10 primary sonographically guided
PSTJ injections completed by the primary investigator in
the Procedural Skills Laboratory was assessed by sono-
graphic documentation of distension of the posterior and
lateral PSTJ recesses. Posterior and lateral PSTJ recess dis-
tension was documented at baseline and after the 2- and
4-mL total volume injections. In addition, the presence of
fluid in the peroneal tendon sheath and sinus tarsi was
determined for each condition. Finally, the presence of
fluid within the middle facet of the ASTJ was assessed after
the 4-mL total volume injection.
The sonographically guided and CT-guided PSTJ
contrast agent injections performed in the Opus Imaging
Research Facility were assessed by the coinvestigator for
contrast flow within the PSTJ, distension of the posterior
and lateral PSTJ recesses, contrast flow within the sinus
tarsi (ie, distension of the anterior recess), and contrast
flow to regions outside the PSTJ. Assessment was per-
formed for both the sonographically guided and CT-
guided PSTJ injections at baseline and after the 2- and
4-mL total volume injections and again after the 6-mL total
volume CT-guided injection.
Statistics
Descriptive statistical analyses were performed to describe
donor age, sex, and BMI for all specimens used during the
investigation. For the 10 primary sonographically guided
PSTJ injections performed via the sinus tarsi approach,
descriptive statistics were used to describe: (1) PSTJ
accuracy as determined by distension of the posterior and
lateral PSTJ recesses; (2) the frequency of posterior
and lateral PSTJ recess distension after the 2- and 4-mL
total volume injections; (3) the frequency of peroneal ten-
don sheath fluid after the 2- and 4-mL total volume injec-
tions; (4) the frequency of fluid within the sinus tarsi after
the 2- and 4-mL total volume injections; and (5) the fre-
quency of fluid within the middle facet of the ASTJ after
the 4-mL total volume injection.
For the sonographically guided and CT-guided PSTJ
contrast agent injections, CT images were interpreted at
each incremental injection volume to assess injection accu-
racy, as determined by the appearance of a typical PSTJ
arthrogram. In addition, posterior PSTJ recess distension,
lateral PSTJ recess distension, and the presence of contrast
in the peroneal tendon sheath were assessed after the 2-
and 4-mL total volume injections. A final assessment of
contrast flow was completed on the specimen receiving a
CT-guided injection after the 6-mL total volume injection.
Results
A total of 10 sonographically guided PSTJ tap water injec-
tions via the sinus tarsi were completed on 10 unembalmed
cadaveric ankle-foot specimens (6 right and 4 left) obtained
from 6 male donors with a mean age of 81.7 years (range,
72–92 years) and an average BMI of 25.7 kg/m2 (range, 15.7–
38.4 kg/m2). Preinjection scanning showed no appreciable
fluid within the PSTJ recesses, sinus tarsi, peroneal tendon
sheath, or middle facet of the ASTJ. No technical limita-
tions were encountered during these injections. All 10
PSTJ injections were accurate, as demonstrated by disten-
sion of both the posterior and lateral PSTJ recesses after
the 4-mL total volume injection. All 10 specimens (100%)
had also showed unequivocal posterior recess distension
by the end of the 2-mL injection, whereas only 2 specimens
(20%) showed lateral recess distension at this injection vol-
J Ultrasound Med 2015; 34:83–93 87
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ume (Figures 3 and 4). Although no specimen showed
fluid in the sinus tarsi at 2 mL, by 4 mL, all 10 specimens
(100%) showed fluid emerging from the depth on the cal-
caneal side of the sinus tarsi and displacing the sinus tarsi
contents superficially (Figure 5). No fluid was seen in the
peroneal tendon sheath or middle facet of the ASTJ in any
specimen at any injection volume. In summary, by the time
2 mL had been injected, fluid was visualized in the poste-
rior recess 100% of the time but in the lateral recess only
20% of the time. By the 4-mL total injection volume, both
the posterior and lateral recesses were clearly distended in
all specimens (the posterior recess being distended to a
greater degree in all specimens), and fluid had also appeared
in the depth of the sinus tarsi on the calcaneal side in all
specimens. No fluid was visualized in the peroneal tendon
sheath or middle facet of the ASTJ in any specimen at any
volume.
The single sonographically guided PSTJ contrast
agent injection via the sinus tarsi approach was completed
on a left ankle-foot specimen obtained from a 77-year-old
male donor with a BMI of 23.5 kg/m2. Preinjection CT
scanning showed no appreciable fluid within the PSTJ
Smith et al—Sonographically Guided Posterior Subtalar Joint Injections
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Figure 3. A, Transducer position for assessing distension of the posterior recess of the PSTJ during sonographically guided PSTJ injection via the
sinus tarsi. Note the necessary angulation of the transducer to direct the ultrasound beam toward the posterior recess. Underlying bony anatomy is
as shown in Figure 2C. B, Correlative sonogram of a cadaveric specimen before injection obtained with the transducer positioning shown in A. The
echogenic bony surfaces of the posterior calcaneus (CALC), talus (TAL), and tibia (TIB) are clearly shown. The yellow arrow indicates the nondis-
tended posterior recess of the PSTJ. Bottom is deep/anterior; left, cephalad; right, caudad (CAUD); and top, superficial/posterior. POST ANKLE LG
indicates posterior longitudinal view of the ankle region. C, Same specimen after injection of 2 mL of normal tap water using the sinus tarsi approach
to the PSTJ. After needle placement, the transducer is repositioned over the posterolateral ankle region, as shown in A. Light transducer pressure is
mandatory. At 2 mL, all specimens showed clear posterior recess distension, as shown here, whereas only 2 of 10 specimens showed lateral recess
distension (see Figure 4). Orientation and labels are as in B. D, Same specimen after a 4-mL total volume injection. There is marked posterior
recess distension but no evidence of capsular rupture. At this injectate volume, all 10 specimens also showed lateral recess distension (see Fig-
ure 4). Orientation and labels are as in B.
A B
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recesses, sinus tarsi, peroneal tendon sheath, or middle
facet of the ASTJ. No technical limitations were encoun-
tered during this injection. The CT contrast pattern for
this injection paralleled that for the sonographically guided
PSTJ tap water injections (Figure 6). By 2 mL, a PSTJ CT
arthrogram was visualized, accompanied by clear disten-
sion of the posterior PSTJ recess but minimal distension
of the lateral PSTJ recess. At 4 mL, the lateral PSTJ recess
was also clearly distended, although the extent of posterior
PSTJ recess distension was still greater. In addition, at
4 mL, contrast clearly distended the anterior aspect of the
PSTJ and flowed into the calcaneal side of the sinus tarsi,
as had been shown on the sonographically guided tap
water injections (Figures 5 and 6C). No contrast was seen
in the peroneal tendon sheath or ASTJ (middle facet and
talonavicular joint, the latter of which was also visualized by
CT; Figure 6C).
The single CT-guided PSTJ contrast agent injection
via the lateral approach was completed on a right ankle-
foot specimen obtained from an 84-year-old male donor
with a BMI of 26.1 kg/m2. Preinjection CT scanning
showed no appreciable fluid within the PSTJ recesses, sinus
tarsi, peroneal tendon sheath, or middle facet of the ASTJ.
No technical limitations were encountered during this
injection. The CT findings during this injection matched
those of the sonographically guided PSTJ contrast agent
injection at both 2 and 4 mL, with the exception of the
observation that by 4 mL, contrast was noted in the per-
oneal tendon sheath (Figure 7A). At 6 mL, disruption of
the posterior PSTJ recess and anterior capsule of the PSTJ
was evident, as shown by irregular contrast flow into the
Kager fat pad and sinus tarsi, respectively (Figure 7B).
Despite the presumed PSTJ capsuloligamentous rupture,
no contrast was visualized in the ASTJ (middle facet and
talonavicular joint), confirming the previously noted
anatomic discontinuity between the ASTJ and PSTJ of the
subtalar joint complex (Figure 7A). 
Discussion
The primary finding of this investigation was that sono-
graphically guided PSTJ injections via the sinus tarsi
approach are feasible and can accurately and specifically
deliver injectate into the PSTJ, as demonstrated in this
J Ultrasound Med 2015; 34:83–93 89
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Figure 4. A, Transducer position (box) for assessing distension of the
lateral recess of the PSTJ. The transducer is placed across the PSTJ
approximately parallel to the calcaneofibular ligament (not shown) and
anterior to the fibula. Similar to the posterior recess, light transducer
pressure is mandatory. B, Correlative sonogram of the lateral recess (LAT
ANKLE COR) after a 2-mL tap water injection into the PSTJ via the sinus
tarsi. Despite the use of light transducer pressure, there is no clear disten-
sion (yellow arrow). Only 2 of 10 specimens showed appreciable lateral
recess distension at 2 mL, suggesting that the lateral recess is not as sen-
sitive as the posterior recess for detecting PSTJ distension during injection.
Bottom is deep/medial; left, cephalad; right, caudad (CAUD); and top,
superficial/lateral. CALC indicates calcaneus; PT, peroneal/fibular tendons;
and TAL, talus. C, Same specimen after a 4-mL PSTJ injection. Lateral
recess distension is clearly visible, as was the case in all 10 specimens at
the 4-mL injection volume. Orientation and labels are as in B.
A
B C
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cadaveric model. Despite the fact that direct sonographic
needle visualization within the PSTJ can be challenging
using this approach, distension of the posterior PSTJ recess
can be used to confirm accurate needle placement.
Several technical considerations are worthy of discus-
sion with respect to the sinus tarsi approach to the PSTJ.
First, the needle trajectory should be anterior to posterior
and pass just superficial and adjacent to the superior sur-
face of the calcaneus. The PSTJ lies on the calcaneal side of
the sinus tarsi, and a posteromedial needle trajectory (as
used for traditional “sinus tarsi” injection) will be less likely
to enter the PSTJ.4,21 In addition, keeping the needle
close to the superior calcaneal surface reduces the likeli-
hood of the needle hitting the anterior talar facet rather
than passing between the talus and calcaneus (Figure 2, C
and D). Second, as previously stated, accurate needle
placement can be confirmed by the development of pos-
terior PSTJ recess distension at a 2-mL injection volume
(Figures 3, A–D, and 6, A and B). After observing the sen-
sitivity of posterior recess distension in our first 5 speci-
mens, the primary investigator elected to dynamically
monitor the posterior recess during the subsequent 5 injec-
tions. In all 5 specimens, posterior recess distension was
clearly evident between the 1- and 2-mL injection volumes.
It cannot be overemphasized that during this assessment,
the operator must use light transducer pressure to increase
the ability to visualize the developing posterior recess effu-
sion. Anchoring the caudad end of the transducer on the
posterolateral calcaneus and floating the cephalad end over
the soft tissues can assist in this regard. Although not exam-
ined as part of this investigation, in clinical practice, the
anterior recess of the tibiotalar joint should also be assessed
for distension when performing PSTJ anesthetic injec-
tion for arthrodesis preoperative planning, as the tibiota-
lar joint communicates with the PSTJ in up to 20% of the
population.8,24 Determining the complete distribution of an
anesthetic injection is important in this scenario to iden-
tify the source of pain, as this information can be used to
predict the site of a successful arthrodesis.17 Third,
although some operators are challenged by out-of-plane
needle approaches, it is our opinion that the relatively large
working space of the sinus tarsi provides greater opportu-
nity to identify the needle tip, readjust as necessary, and
appropriately track it to the target. The lack of major neu-
rovascular structures within the sinus tarsi may also be reas-
suring to operators less experienced with out-of-plane
injection techniques such as described herein (Figures 1
and 2B).21 Nonetheless, in the primary investigator’s expe-
rience, the sonographically guided PSTJ injection via the
sinus tarsi can be performed using an in-plane approach
with the transducer positioned in the axial plane at the level
of the superior calcaneal surface and directed medially. The
needle trajectory is the same as that used for the described
out-of-plane approach (Figure 8). In our opinion, the
choice of using an out-of-plane or in-plane approach for
the injection described herein may largely be a matter of
practitioner preference and patient-specific factors. Further
experience and research pertaining to each approach may
provide further clarification in this regard.
Although we did not directly compare the sinus tarsi
approach to the previously published sonographically
guided PSTJ techniques, accessing the PSTJ through the
sinus tarsi provides several potential advantages. The sinus
tarsi approach does not place the needle near major neu-
rovascular structures as does the posteromedial approach
and may be less likely to be impeded by congenital, post-
traumatic, or postoperative anatomic changes than the
anterolateral and posterolateral approaches.5,10 Furthermore,
as most patients with systemic polyarthritis involving the
PSTJ will also have synovitis in the sinus tarsi, it may be
desirable to access the sinus tarsi and PSTJ with a single
needle for patient comfort and procedural efficiency.25
This consideration may also be the case when treating
patients with combined PSTJ pain and sinus tarsi syn-
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Figure 5. Sonogram of the sinus tarsi in a cadaveric specimen using the
transducer positioning shown in Figure 2, A and B. After a 4-mL PSTJ
injection, fluid is shown emerging from the depth on the calcaneal side of
the sinus tarsi (asterisk). This fluid is thought to represent distension
of the anterior capsule of the PSTJ and suggests that PSTJ effusions
may be visualized sonographically in the sinus tarsi. Bottom is deep/
posterior; left, superior/dorsal; right, inferior/plantar; and top, superficial/
anterior. CALC indicates calcaneus; and TAL, talus.
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drome or aspirating sinus tarsi ganglion cysts and injecting
their joint of origin, which is typically the PSTJ.13,21,25
The use of CT during this investigation validated and
reinforced our sonographic findings by allowing us to glob-
ally visualize contrast flow patterns after sonographically
guided and CT-guided injections. Although executed
through different approaches, the sonographically guided
and CT-guided PSTJ contrast agent injections produced
excellent and equivalent PSTJ arthrograms (Figures 3, C and
D, and 6, A and B). Furthermore, the CT arthrograms
showed a pattern of posterior-greater-than-lateral recess
distension that paralleled the distension observed during
the sonographically guided PSTJ tap water injections.
Finally, CT confirmed the sonographic observation that
accurately placed PSTJ injections do not flow into the
ASTJ under normal circumstances, confirming that these
regions are anatomically distinct. This separation continued
even during the 6-mL CT-guided contrast agent injection,
which resulted in anterior and posterior PSTJ capsular
ruptures (Figures 1, 6C, and 7A).
There are several potential study limitations that
should be considered when interpreting the results of this
investigation. First, operators should use appropriate cau-
tion when extrapolating our results in a relatively small num-
ber of normal cadaveric specimens to clinical populations.
Reassuringly, the primary author has used the sinus tarsi
approach on several patients with 100% accuracy, as demon-
strated by posterior and lateral PSTJ recess distension.
Second, a single experienced operator performed all sono-
graphically guided injections during this study. The use
J Ultrasound Med 2015; 34:83–93 91
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Figure 6. A, Sagittal postarthrographic CT scan of an anatomic speci-
men after sonographically guided PSTJ injection via the sinus tarsi with
2 mL of the diluted contrast agent. Clear distension of the posterior
recess is shown (yellow arrow), correlating with Figure 3C. In addition,
some contrast is also shown at the depth within the sinus tarsi (white
arrow), although sinus tarsi distension was not appreciated sonograph-
ically at the 2-mL volume. Bottom is caudad; left, anterior; right, posterior;
and top, cephalad. C indicates calcaneus; Ta, talus; and Ti, tibia. B, Same
anatomic specimen after a total 4-mL diluted contrast agent injection.
Compared with A, the posterior recess distension has increased, as has
the presence of fluid within the sinus tarsi. These findings correlate sono-
graphically with Figures 3D and 5. Orientation and labels are as in A. C,
Axial oblique CT scan of the same specimen at the 4-mL contrast agent
injection volume. From this perspective, the needle tip is shown in the
anterior aspect of the PSTJ (black circle). White arrow indicates disten-
sion of the anterior aspect of the PSTJ emerging into the calcaneal por-
tion of the sinus tarsi (compare with B and Figure 5); and yellow arrow,
middle facet of the ASTJ devoid of contrast. Bottom is posterior; left, lat-
eral; right, medial; and top, anterior. Labels are as in A.
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of a single operator was intentional to ensure technical
consistency. Although the sinus tarsi approach may be
more technically challenging for some operators, we
believe that accuracy can be ensured by monitoring pos-
terior recess distension, as previously discussed. Third, we
did not assess for iatrogenic injury to the sinus tarsi struc-
tures as part of this investigation. Both image-guided and
nonguided sinus tarsi injections have been performed for
many years without reported complications. In our opin-
ion, the sinus tarsi approach to the PSTJ described herein
should not offer a different risk profile compared to the pal-
pation- and image-guided sinus tarsi injections that have
been performed for decades. Nonetheless, we typically use
Doppler imaging during sinus tarsi procedures to avoid
large vessels when possible.
In conclusion, sonographically guided PSTJ injections
via the sinus tarsi can accurately and specifically deliver injec-
tate into the PSTJ while monitoring injectate flow within the
posterior recess. The sinus tarsi approach may be used as an
alternative technique for performing sonographically guided
PSTJ injections when clinically appropriate.
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Figure 7. A, Coronal oblique CT arthrogram showing the needle posi-
tioning for the CT-guided PSTJ injection performed using a lateral approach.
After a 6-mL diluted contrast agent injection, contrast has appeared in
the peroneal tendon sheath. However, no contrast is visualized in the
middle facet of the ASTJ (yellow arrow) despite the large volume injection.
Bottom is caudad/posterior; left, lateral; right, medial; and top, cepha-
lad/anterior. C indicates calcaneus; and Ta, talus. B, Sagittal CT image of
same anatomic specimen after the CT-guided 6-mL diluted contrast
agent injection into the PSTJ. At 6 mL, there is disruption of the posterior
capsule of the PSTJ with contrast extravasation into the Kager fat pad
(yellow arrow). In addition, contrast is visualized extending to the sur-
face of the sinus tarsi (top white arrow) and also surrounding the medial
root of the inferior extensor retinaculum (bottom white arrow). These
findings are suggestive of anterior capsular rupture. Despite the damage
to the PSTJ capsule, contrast did not appear in the middle facet of the
PSTJ, as shown in A. Bottom is caudad; left, anterior; right, posterior; and
top, cephalad. Cb indicates cuboid; and Ti, tibia; other labels are as in B.
A
Figure 8. Setup for the in-plane approach for the PSTJ injection per-
formed via the sinus tarsi. The transducer is placed in an anatomic axial
plane parallel and just cephalad to the superior border of the anterior
process of the calcaneus. The needle is advanced using an in-plane,
anterior-to-posterior approach along a trajectory similar to Figure 2C.
Note that the trajectory of the needle is slightly caudad in an anterior-to-
posterior direction.
B
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